Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1

Conditions

Leukemia, Myeloid, Acute 8Leukemia 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma 6Myelodysplastic Syndromes 4Multiple Myeloma 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia, Lymphocytic, Chronic, B-Cell 4Neoplasms, Plasma Cell 3Burkitt Lymphoma 3Waldenstrom Macroglobulinemia 2Myeloproliferative Disorders 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myeloid 2Leukemia, Biphenotypic, Acute 2Hematologic Diseases 2Congenital Abnormalities 2Thrombocythemia, Essential 1Shwachman-Diamond Syndrome 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Recurrence 1Primary Myelofibrosis 1Preleukemia 1Precancerous Conditions 1Polycythemia Vera 1Osteosarcoma 1Neuroblastoma 1Neoplasms by Histologic Type 1

Interventions

fludarabine phosphate 47Peripheral Blood Stem Cell Transplantation 39Cyclophosphamide 39Busulfan 37Tacrolimus 33Mycophenolic Acid 29Methotrexate 26Cytarabine 25Cyclosporine 25Whole-Body Irradiation 24Antilymphocyte Serum 23Radiotherapy 16Etoposide 16Filgrastim 15Methylprednisolone 11Melphalan 11Transplantation 9Cord Blood Stem Cell Transplantation 9Idarubicin 8sargramostim 7Sirolimus 7Mitoxantrone 7merphos 6Thiotepa 6Granulocyte Colony-Stimulating Factor 6Flow Cytometry 6Alemtuzumab 6fludarabine 5aldesleukin 5Gemtuzumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Congenital Abnormalities × Bone Marrow Transplantation × Clear all
NCT00534469 2025-12-02

Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R

City of Hope Medical Center

Phase 2 Completed
60 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT00066417 2013-05-01

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

National Cancer Institute (NCI)

Phase 2 Terminated
51 enrolled
MyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡